Jozef Madzo to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Jozef Madzo has written about Drug Resistance, Neoplasm.
Connection Strength
0.304
-
ZNF251 haploinsufficiency confers PARP inhibitors resistance in BRCA1-mutated cancer cells through activation of homologous recombination. Cancer Lett. 2025 Mar 31; 613:217505.
Score: 0.171
-
TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors. Cancer Res. 2021 10 01; 81(19):5089-5101.
Score: 0.133